Pharmacists in Bismarck, North Dakota


157 Pharmacists found in Bismarck
female pharmacist

Stefanie Jangula


Pharmacist
1225 E Calgary Ave, Bismarck, ND 58503
701-223-9323    

female pharmacist

Mrs. Tamara Ruggles, PHARMD


Pharmacist
4730 Granite Dr, Bismarck, ND 58503
701-343-1970    

female pharmacist

Tamara Marie Balerud, PHARMD


Pharmacist
900 E Broadway Ave, Bismarck, ND 58501
701-530-6906    



female pharmacist

Tanya Lee Brosz, PHARMD


Pharmacist
1304 E Boulevard Ave, Bismarck, ND 58501
701-224-0175    

male pharmacist

Mr. Terrance Robert Kristensen


Pharmacist
401 N 9th St, Bismarck, ND 58501
701-530-6050    

male pharmacist

Mr. Thomas Frank Simmer, R.PH


Pharmacist
Medcenter One Pharmacy, 300 N 7th St Box 5525, Bismarck, ND 58506
701-323-8606     701-323-6988

male pharmacist

Mr. Thomas Fredrick Uhde, PHARMD


Pharmacist
3101 N 11th St, Bismarck, ND 58503
701-224-9521    

female pharmacist

Tiana Ramos, PHARMD


Pharmacist
900 E Broadway Ave, Bismarck, ND 58501
701-530-6906    

female pharmacist

Tifany Kathryn Steenstra


Pharmacist
835 S Washington St Ste 2, Bismarck, ND 58504
701-223-1656    

male pharmacist

Dr. Troy Vernon Hertz, PHARMD


Pharmacist
300 N 7th St, Bismarck, ND 58501
701-323-6186     701-323-6988

male pharmacist

Tucker Kreft, PHARMD


Pharmacist
300 N 7th St, Bismarck, ND 58501
701-323-6186    

female pharmacist

Mrs. Valerie Sturlaugson, RPH


Pharmacist
1304 E Blvd Ave, Bismarck, ND 58501
701-224-0175     701-224-1285

male pharmacist

Zach Storey


Pharmacist
3101 N 11th St, Bismarck, ND 58503
701-224-9521    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.